Exogenous augmenter of liver regeneration (ALR) attenuates inflammatory response in renal hypoxia re-oxygenation injury

Renal Failure

Volumn 36, Issue 3, 2014, Pages 432-436

  Li, Ying ^a   Zhang, Ling ^a   Liu, Qi ^a   Chen, Guo Tao ^a   Sun, Hang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Augmenter of liver regeneration; Hypoxia re oxygenation; Inflammatory response; NRK 52E cells; Renal ischemia reperfusion injury; Toll like receptor 4

Indexed keywords

AUGMENTER OF LIVER REGENERATION PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; SCATTER FACTOR; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; AUGMENTER OF LIVER REGENERATION FACTOR; MESSENGER RNA; PROTEIN; TLR4 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL HYPOXIA; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE EXPRESSION; IMMUNE RESPONSE; INFLAMMATION; KIDNEY INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REOXYGENATION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; INNATE IMMUNITY; KIDNEY; MALE; METABOLISM; VASCULARIZATION;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EPITHELIAL CELLS; IMMUNITY, INNATE; INTERLEUKIN-1BETA; INTERLEUKIN-6; KIDNEY; MALE; NF-KAPPA B; PROTEINS; RATS; REPERFUSION INJURY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84896484540     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.867811     Document Type: Article

References (24)

1. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol. 2008;109:e102-e107.
2. Wlico GJT, Pulskens P, Butter LM, et al. TLR4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS One. 2008;3:3596.
3. Jang HR, Ko GJ, Wasowska BA. The interaction between ischemiareperfusion and immune responses in the kidney. J Mol Med (Berl). 2009;87:859-864.
4. Boros P, Bromberg J. New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant. 2006; 6:652-658.
5. Shigeoka AA, Holscher TD, King AJ, et al. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol. 2007;178:6252-6258.
6. Cunningham PN, Wang Y, Guo R, He G, Quigg RJ. Role of Tolllike receptor 4 in endotoxin-induced acute renal failure. J Immunol. 2004;172:2629-2635.
7. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005;17:1-14.
8. Wu H, Chen G, Wyburn KR, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest. 2007;117: 2847-2859.
9. Giorda R, Hagiya M, Seki T, et al. Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol Med. 1996;2:97-108.
10. Liao XH, Zhang L, Tang XP, et al. Expression of augmenter of liver regeneration in rats with gentamicin-induced acute renal failure and its protective effect on kidney. Ren Fail. 2009;31: 946-955.
11. Liao XH, Zhang L, Liu Q, et al. Augmenter of liver regeneration protects kidneys from ischemia/reperfusion injury in rats. Nephrol Dial Transplant. 2010;25:2921-2929.
12. Gandhi CR. Augmenter of liver regeneration. Fibrogen Tissue Repair. 2012;5:10.
13. Francavilla A, Vujanovic NL, Polimeno L, et al. The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions. Hepatology. 1997;25: 411-415.
14. Tanigawa K, Sakaida I, Masuhara M, et al. Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases. J Gastroenterol. 2000;35:112-119.
15. Liu Q, Wang XG, Sun H. Effect of human augmenter of liver regeneration on PKCa-NF-kB expressions and IL-2 secretion in peripheral mononuclear cells. Acta Acad Med Militaris Tertiae. 2009;31:2065-2068.
16. Liu Q, Wang XG, Sun H. Variation and function of ERK in ALRmediated immunosuppression. Chin J Immuol. 2010;26:128-131.
17. Liu Q, Yu HF, Sun H, Ma HF. Expression of human augmenter of liver regeneration in Pichia pastoris yeast and its bioactivity in vitro. World J Gastroenterol. 2004;10:3188-3190.
18. Nichols TC. NF-kB and reperfusion injury. Drug News Perspect. 2004;17:99-104.
19. Wolfs TG, Buurman WA, Schadewijk AV, et al. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-g and TNF-a mediated up-regulation during inflammation. J Immunol. 2002;168:1286-1293.
20. Fausto N, Laird A, Webber E. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J. 1995;9: 1527-1536.
21. Starzl T, Terblanche J, Porter K, et al. Growth-stimulating factor in regenerating canine liver. Lancet. 1979;313:127-130.
22. Francavilla A, Hagiya M, Porter KA, et al. Augmenter of liver regeneration: its place in the universe of hepatic growth factors. Hepatology. 2005;20:747-757.
23. Liao XH, Chen GT, Li Y, et al. Augmenter of liver regeneration attenuates tubular cell apoptosis in acute kidney injury in rats: the possible mechanisms. Ren Fail. 2012;34:590-599.
24. Zhou J, Zhang CL, Zhang L. Hypoxia stimulated augmenter of liver regeneration in rat proximal tubular epithelial cells (NRK52E). J Chongqing Med Univ. 2011;3:003.